Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic Cancer
Summary
The purpose of this phase I trial is to test the safety and feasibility of combination treatment, cabozantinib, and atezolizumab in patients with metastatic pancreatic cancer.
General Information
NCT#: NCT04820179
Study ID: 2108097176
Trial Phase: Phase II
Trial Sponsor: University of Arizona
Therapies Used in This Trial: Cabozantinib, Atezolizumab